Latarcin 2a

General Information


DRACP ID  DRACP00433

Peptide Name   Latarcin 2a

Sequence  GLFGKLIKKFGRKAISYAVKKARGKH

Sequence Length  26

UniProt ID  Q1ELU1 

PubChem CID  Not available

Origin  Central Asian spider, Lachesana tarabaevi

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Breast tumor cell Breast tumor Carcinoma graph fig 8 A LDH leakage assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  2G9P 

Predicted Structure  DRACP00433

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C136H229N41O29

Absent amino acids  CDEMNPQTW

Common amino acids  K

Mass  334868

Pl  11.97

Basic residues  10

Acidic residues  0

Hydrophobic residues  10

Net charge  10

Boman Index  -3802

Hydrophobicity  -43.85

Aliphatic Index  82.69

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  59.6

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22885172

Title  Imaging the membrane lytic activity of bioactive peptide latarcin 2a

Doi 10.1016/j.bbamem.2012.07.030

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.